Tablet system helps psychiatrists assess near-term suicide risk


A tablet-based tool is nearly as good as a psychiatrist in assessing near-term suicide risk, according to a new study published in the Journal of Clinical Psychiatry.

The mHealth approach is also proving to be much quicker, and patients describe it as easy to use, according to a University of Vermont article.

“We’ve demonstrated for the first time that a simple, quick model can accurately predict a psychiatrist’s assessment of near-term risk for suicide,” said lead study author Isabelle Desjardins, M.D., an associate professor of psychiatry and medical director of inpatient psychiatry at the University of Vermont.

Digital Transformation

Unlock the Digital Front Door with an App

The Member Mobile App is the smarter and better way to engage members anytime and anywhere. Members can find the right doctors, receive alerts, track spending, use telehealth, and more — all within a guided, intuitive, and seamless experience. Built exclusively for payers, it is ready to install and launch in a few months. Request a consult on how to enable the digital front door with the Mobile App, today.

“To have a tool to standardize risk assessment efficiently is the first step toward meeting the Joint Commission mandate. Perhaps most importantly, this tool can be most helpful in identifying individuals at risk by augmenting clinical decision support in settings where with scarce psychiatry resources,” Desjardins added.

Mobile devices, such as tablets and smartphones, are increasingly being tapped for new healthcare treatment approaches and clinical evaluations. As FierceMobileHealthcare reported in late 2015, the U.S. Food and Drug Administration approved a mobile spirometer, boasting Bluetooth sensors and working off a smartphone or tablet.

The tablet-based suicide risk evaluation approach featured key questions and compared the mobile format to a psychiatrist interview model.

“An expert-based neural network model predicted psychiatrists’ assessments of risk of suicide in the hospital within 72 hours. It replicated psychiatrist-recommended interventions to mitigate risk in EDs and medical/surgical units,” the study states.

For more information:
- read the University of Vermont article

Suggested Articles

There is a potential legal skirmish brewing two of the largest telehealth companies over patent claims.

Buoyed by strong demand for its stock, GoodRx raised $1.1 billion in its IPO after pricing its deal well above its expected price range.

Microsoft's new healthcare cloud service will be generally available October 30 as the tech giant battles Google and Amazon in the cloud market.